Realta Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Realta Investment Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-270	Closed	-$284K	–	680
2024 Q2	$284K	Buy	270 +4	+2%	+$3.88K	0.06%	322
2024 Q1	$256K	Buy	+266	New	+$253K	0.05%	348
2020 Q1	–	Sell	-169	Closed	-$62K	–	1143
2019 Q4	$62K	Hold	169	–	–	0.02%	620
2019 Q3	$47K	Hold	169	–	–	0.01%	698
2019 Q2	$53K	Sell	169 -2	-1%	-$666	0.01%	659
2019 Q1	$71K	Buy	+171	New	+$70.4K	0.03%	464

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Realta Investment Advisors's REGN Position: Q3 2024 in Review

Realta Investment Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q3 2024, closing a stake of 270 shares — an estimated $284K sold.

Realta Investment Advisors first reported a position in REGN in Q1 2019 and held it in 6 quarters. The position peaked at $284K in Q2 2024. 1,388 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

Realta Investment Advisors reported no remaining Regeneron Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Realta Investment Advisors sold 270 Regeneron Pharmaceuticals shares in Q3 2024, an estimated $284K.
Realta Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2019 and held it in 6 quarters.
Realta Investment Advisors's Regeneron Pharmaceuticals position peaked at $284K in Q2 2024.
1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on Realta Investment Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.